Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases

18 Jun 2024

Abstract excerpt

The use of nanomaterials in gene editing and synthetic biology has emerged as a pivotal strategy in the pursuit of refined treatment methodologies for pulmonary disorders. This review discusses the utilization of nanomaterial-assisted gene editing tools and synthetic biology techniques to promote the development of more precise and efficient treatments for pulmonary diseases. First, we briefly outline the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to RNA Interference and Gene Delivery
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38890749
DOI: 10.1186/s12951-024-02627-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseasesPMID 38890749Read ↗

Inhalation delivery technology for genome-editing of respiratory diseasesSemantic proximity Read ↗

Unlocking the potential of RNA-based therapeutics in the lung: current status and future directionsSemantic proximity Read ↗

Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory DiseasesSemantic proximity Read ↗

Functioning human lung organoids model pulmonary tissue response from carbon nanomaterial exposuresSemantic proximity Read ↗

Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic FibrosisSemantic proximity Read ↗

Progress in Respiratory Gene TherapySemantic proximity Read ↗

Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cellsSemantic proximity Read ↗

Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical TargetsSemantic proximity Read ↗

Advancements in gene therapy for lung cancer: from genetic insights to clinical applicationsSemantic proximity Read ↗

Base editing and nanoparticle transfection of airway cell types essential for treatment of cystic fibrosisSemantic proximity Read ↗

Genetic Modification of the Lung Directed Toward Treatment of Human DiseaseSemantic proximity Read ↗

Aerosol Inhalation of Gene Delivery Therapy for Pulmonary DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.